Subscribe
Deep Dive: A Dutch retailer is behind the company鈥檚 share price growth, and it鈥檚 time to question how long it can continue
Deep Dive: The FTSE 100 pharma giant is trying a new, but risky, approach to developing new drugs
Deep Dive: A sharp-eyed underwriting record is its chief differentiator in an industry where it鈥檚 difficult to stand out
Deep Dive: The sportswear retailer has made some big investments聽鈥� but how likely are they to pay off?
Deep Dive: With no weight-loss drug and a focus on cancer, the FTSE 100 giant needs to perfectly manage its patent cliff-edge
It has many fingers in many pies, but is still a reliable dividend payer. We look at whether it can keep on providing
Deep Dive: The telecom is on the verge of a major shift in cash flows 鈥� but a lot has to go right
Deep Dive: Artificial intelligence and big tech are threatening the company鈥檚 business model, as new growth avenues dry up
Japan鈥檚 premier corporation, and the world鈥檚 largest carmaker, is pursuing a more nuanced approach to the EV transition
Deep Dive: We deliver our own rating on the credit scorer
